← brief for 2026-10-25 · Slowing decline

Sodium-Glucose Cotransporter 2 Inhibitor Use and Levels of Hemoglobin, Markers of Iron Metabolism, and Erythropoiesis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

This large review combined data from many clinical trials to look at a common diabetes drug. It found that people taking this drug had higher levels of hemoglobin, a protein in red blood cells. This is a strong finding because it is based on many studies. Higher hemoglobin can help the body carry oxygen better.

Who did this work

Yang Y · Yang C · Wang Y · Rawee P · Cases A · Leaf DE · Del Vecchio L · Muka T · Heerspink HJL · Gansevoort RT · Eisenga MF

Source

Article · PubMed, the drug frontier · 2026 Oct 24
https://pubmed.ncbi.nlm.nih.gov/42925557/